Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin and Dextromethorphan in Older Adults With Low Well-being
NCT07386730Phase 1Recruiting
- Start
- Jun 2026
- Primary completion
- Feb 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin in anhedonia ((none)) (4 arms). Primary endpoint: Acute changes in EEG-based ESBA at 2 hours. Started Jun 2026; status: recruiting.
02
Drugs
psilocybin
03
Conditions
anhedonia ((none))
Beyond the preview
Go deeper on NCT07386730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07386730.